Trial results for new lung cancer drug are ‘off the charts’, say doctors
Trial results for new lung cancer drug are ‘off the charts’, say doctors
More than half of patients with advanced forms of disease who took lorlatinib were still alive after five years with no progression
Doctors are hailing “off the chart” trial results that show a new drug stopped lung cancer advancing for longer than any other treatment in medical history.
Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8m deaths every year. Survival rates in those with advanced forms of the disease, where tumours have spread, are particularly poor.
More than half of patients (60%) diagnosed with advanced forms of lung cancer who took lorlatinib were still alive five years later with no progression in their disease, data presented at the world’s largest cancer conference showed. The rate was 8% in patients treated with a standard drug, the trial found.
The results are the longest progression-free survival (PFS) outcomes ever recorded in patients with non-small cell lung cancer, the world’s most common form of the disease. They were presented at the annual meeting of the American Society of Clinical Oncology (Asco) in Chicago on Friday.
I don't normally comment on news posts, but in this instance, FUCK CANCER
Fuck cancer for stealing my brother from me, and for taking half my bf's lung
I seriously hopes this works for everyone out there living with this disease, and for their families, friends, the people who love them....
.....and also for everyone who has died too soon and missed their chance for survival. Their donation of tissue samples and furthering the cancer research that ultimately wouldn't help them, but will help the poor bastards that are diagnosed today and in the future...It is bitter sweet
Fuck cancer
Fuck cancer all the way. Every step further in stopping it is a win. And this seems like it might be a particularly great step.
Fuck yes.
It's the second major medical breathrough this week. If they both turned out true, that would be incredible.
What was the other one?
I think it was a promising treatment for type 2 diabetes.
Effectively a cure for Diabetes I believe
That's awesome to hear, but I'm sure it'll be unaffordable for many—if not most—people who need it... at least in the US. :(
It's great news for Europe, though! I'm glad for them.
doctors further said that once the results where back on the charts it showed a beneficial effect.
I assumed their charts were showing real numbers and their numbers were imaginary.
So... smoke 'em if you got 'em.
Smoking can also cause cancer in the larynx, mouth, pharynx, esophagus, pancreas, bladder, stomach, colon, rectum, liver, cervix, kidney, and blood. It's by no means a free pass.
I know, I was kidding. It's an old phrase from WWII.
Well that's a hilarious tinfoil hat theory- that lung-cancer-fighting drugs are financed by Big Tobacco as a way for them to sell more cigarettes.
And honestly, is there anything more late-stage capitalism than "who cares if this activity causes you cancer; you can just take a pill to make it go away!"
-The above post was brought to you by Lucky Strikes, the cigarette that causes the most treatable form of cancer!
Lung cancer killed my pet and I imagine it killed many other people's pets too. Cancer also killed some of my other pets.
Pfizer to the moon!
This is the best summary I could come up with:
Doctors are hailing “off the chart” trial results that show a new drug stopped lung cancer advancing for longer than any other treatment in medical history.
The results are the longest progression-free survival (PFS) outcomes ever recorded in patients with non-small cell lung cancer, the world’s most common form of the disease.
“To our knowledge these results are unprecedented,” said the study’s lead author, Dr Benjamin Solomon, a medical oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia.
“You don’t need a magnifying glass to see the difference between these two drugs,” said Dr Julie Gralow, Asco’s chief medical officer.
Dr David Spigel, the chief scientific officer of the Sarah Cannon Research Institute in London, a world-leading clinical trials facility specialising in new therapies for cancer patients, welcomed the findings.
“Showcasing the power of cancer-growth blocker drugs, this study could present us with an effective way of stopping cancer in its tracks and preventing it from spreading to the brain.
The original article contains 639 words, the summary contains 161 words. Saved 75%. I'm a bot and I'm open source!
As in good, right?
RIGHT?